Column Group IV-A, LP — SEC Form 4 filings
SEC reporting owner CIK 1796353. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-04-08 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 2,206,960 shares, $39,150,725 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: purchase of 1,437,323 shares @ $18.00 ($25,871,814) in Eikon Therapeutics, Inc., filed 2026-02-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. (EIKN) | 10% owner | 2 | 4 legs · 2,206,960 sh · $39,150,725 | — | 14 |
| NGM BIOPHARMACEUTICALS INC (NGM) | 10% owner | 1 | — | — | 14 |
| RAPT Therapeutics, Inc. (RAPT) | 10% owner | 1 | — | — | 4 |
Form 4 filings — Column Group IV-A, LP
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Purchase (P): 89,200 @ $11.56 | EDGAR |
| 2026-02-09 | 4 | Eikon Therapeutics, Inc. (EIKN) jointly with Column Group IV GP, LP, Column Group IV, LP, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP, TCG Opportunity III GP, LLC, Kutzkey Tim, Svennilson Peter | Conversion (C): 1,296,629 · Conversion (C): 1,403,568 · Conversion (C): 110,928 · Conversion (C): 44,249 · Conversion (C): 47,898 · Conversion (C): 3,785 · +11 more | EDGAR |
| 2024-12-23 | 4 | RAPT Therapeutics, Inc. (RAPT) jointly with COLUMN GROUP II, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC | Other (J): 1,352,008 · Other (J): 1,599,417 · Other (J): 1,352,008 (derivative) · Other (J): 1,599,417 (derivative) | EDGAR |
| 2024-04-08 | 4 | NGM BIOPHARMACEUTICALS INC (NGM) jointly with COLUMN GROUP GP, LP, COLUMN GROUP III, LP, COLUMN GROUP III-A, LP, COLUMN GROUP III GP, LP, Column Group IV, LP, Column Group IV GP, LP, TCG IV GP, LLC, Column Group Opportunity III, LP, Column Group Opportunity III GP, LP | Disposition to issuer (D): 949,862 · Disposition to issuer (D): 2,650,177 · Disposition to issuer (D): 90,442 · Disposition to issuer (D): 11,103,333 · Disposition to issuer (D): 858,035 · Disposition to issuer (D): 968,990 · +8 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796353 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →